With President Donald Trump and Democrats both seeking healthcare policy wins ahead of the 2020 presidential election, Congress will likely pass drug pricing legislation by the end of the year, according to an RBC Capital Markets investors note cited by CNBC.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,